July 19, 2018 / 12:10 PM / 5 months ago

BRIEF-Molecular Partners And Allergan Announce Two Positive Phase 3 Clinical Trials

July 19 (Reuters) - MOLECULAR PARTNERS AG:

* Allergan And Molecular Partners Announce Two Positive Phase 3 Clinical Trials For Abicipar Pegol 8 And 12-Week Regimens For The Treatment In Patients With Neovascular Age-Related Macular Degeneration Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below